Charles Schwab Investment Management Inc. Has $16.23 Million Holdings in Clarivate PLC $CLVT

Key Points

• Charles Schwab Investment Management Inc. reduced its stake in Clarivate PLC by 3.8%, selling 164,935 shares, and now owns 4,129,983 shares worth approximately $16.23 million.
• Vanguard Group Inc. and Truffle Hound Capital LLC increased their positions in Clarivate, with Vanguard acquiring an additional 218,938 shares, raising its stake by 2.5% during the same period.
• Following a recent earnings report, Clarivate maintained a guidance of 0.600-0.700 EPS for FY 2025, with analysts predicting an average EPS of 0.63 for the current year.

Charles Schwab Investment Management Inc. reduced its holdings in Clarivate PLC (NYSE:CLVT - Free Report) by 3.8% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,129,983 shares of the company's stock after selling 164,935 shares during the period. Charles Schwab Investment Management Inc. owned approximately 0.60% of Clarivate worth $16,231,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of the business. Price T Rowe Associates Inc. MD lifted its holdings in Clarivate by 53.6% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 27,776,892 shares of the company's stock valued at $141,107,000 after buying an additional 9,691,104 shares during the period. AustralianSuper Pty Ltd bought a new position in Clarivate during the 1st quarter worth approximately $39,593,000. Vanguard Group Inc. grew its holdings in Clarivate by 2.5% during the first quarter. Vanguard Group Inc. now owns 8,969,796 shares of the company's stock valued at $35,251,000 after purchasing an additional 218,938 shares during the period. Invenomic Capital Management LP grew its holdings in Clarivate by 11.3% during the fourth quarter. Invenomic Capital Management LP now owns 6,585,707 shares of the company's stock valued at $33,455,000 after purchasing an additional 667,146 shares during the period. Finally, Atairos Partners GP Inc. acquired a new position in Clarivate during the fourth quarter valued at approximately $17,602,000. 85.72% of the stock is currently owned by institutional investors and hedge funds.

Clarivate Stock Down 3.7%

CLVT stock traded down $0.16 during mid-day trading on Thursday, hitting $4.32. 3,743,119 shares of the company were exchanged, compared to its average volume of 4,722,892. The company has a debt-to-equity ratio of 0.90, a quick ratio of 0.91 and a current ratio of 0.91. The firm has a market cap of $2.90 billion, a P/E ratio of -6.96 and a beta of 1.40. The firm's 50 day simple moving average is $4.24 and its 200 day simple moving average is $4.17. Clarivate PLC has a 1-year low of $3.04 and a 1-year high of $7.15.

Clarivate (NYSE:CLVT - Get Free Report) last announced its earnings results on Wednesday, July 30th. The company reported $0.18 EPS for the quarter, hitting the consensus estimate of $0.18. The firm had revenue of $621.40 million for the quarter, compared to the consensus estimate of $587.17 million. Clarivate had a negative net margin of 17.33% and a positive return on equity of 8.65%. The business's quarterly revenue was down 4.4% on a year-over-year basis. During the same period last year, the company posted $0.20 EPS. Clarivate has set its FY 2025 guidance at 0.600-0.700 EPS. On average, sell-side analysts predict that Clarivate PLC will post 0.63 EPS for the current fiscal year.

Insider Activity

In other news, insider James Gordon Samson sold 100,000 shares of Clarivate stock in a transaction that occurred on Tuesday, July 1st. The shares were sold at an average price of $4.53, for a total value of $453,000.00. Following the sale, the insider directly owned 1,271,103 shares in the company, valued at $5,758,096.59. This trade represents a 7.29% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 23.18% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on CLVT shares. Jefferies Financial Group started coverage on shares of Clarivate in a report on Friday, July 18th. They set a "hold" rating and a $4.50 price objective for the company. Wall Street Zen cut shares of Clarivate from a "buy" rating to a "hold" rating in a report on Saturday, June 21st. Three equities research analysts have rated the stock with a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company has a consensus rating of "Reduce" and a consensus price target of $4.83.

Clarivate Profile

Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.